Search results

Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
AHA 23: The ORFAN Study
Author(s): Charalambos Antoniades Added: 4 months ago
AHA 23 — In this brief interview, we are joined by Prof Charalambos Antoniades (Oxford University, UK) to discuss the ORFAN trial, sponsored by the University of Oxford.ORFAN is a prospective, multicenter, observational study that collected CT scans, biological material and outcomes data to develop and validate biomarkers of cardiometabolic risk. The registry included 250000 unselected… View more

Digital Health

Prevention & Chronic Conditions
Risk Scoring in Coronary Artery Disease
Author(s): Davide Capodanno Added: 3 years ago
Although a combination of multiple strategies to prevent and treat coronary artery disease (CAD) has led to a relative reduction in cardiovascular mortality over recent decades, CAD remains the greatest cause of morbidity and mortality worldwide.1 Based on clinical presentation and prognosis, CAD spans from stable presentations (e.g. chronic angina pectoris) to acute coronary syndromes (ACS),… View more

Vascular Disease and Surgery

Intervention
A30 - Risk Stratification-based Left Ventricular Global Longitudinal Strain is a Better Predictor of Early Outcome in Patients with Cardiogenic Shock Complicating Acute MI
Author(s): Surenjav Chimed , Batmyagmar Khuyag Added: 4 years ago

MI/ACS
Immediate Impact Without the Need for Thrombolytics in the Treatment of Acute Pulmonary Embolism
Author(s): Felix Mahfoud , Nils Kucher Added: 1 year ago
Pulmonary Embolism is a common disease with a challenging diagnosis. It is the third leading cause of cardiovascular mortality after heart attack and stroke. Despite high mortality rates, anticoagulation alone remains the mainstay treatment for nearly half of the patients diagnosed with PE. 20-50% of them have residual thrombus after receiving conservative treatment, developing life limiting… View more

Prevention & Chronic Conditions

Intervention
Where Do Potent P2Y12 Inhibitors Fit Into Current Practice?
Author(s): Philippe Gabriel Steg Added: 1 year ago
This broadcast series 'Where Do Potent P2Y12 Inhibitors Fit Into Current Practice?'will reappraise potent P2Y12 inhibitors, as evidence accumulates to support their broader use. At this juncture, there is still some uncertainty around patient selection, initiation and long-term management. The fourth, and final, broadcast in this series, focused on Stroke Prevention.In this on-demand… View more

Prevention & Chronic Conditions
Author(s): Anna Caggegi , Davide Capodanno , Claudia Tamburino , et al Added: 3 years ago
Identifying the most appropriate revascularisation strategy for patients affected by unprotected left main coronary artery (ULMCA) disease has been considered a topic of great interest and discussion in the past few years. Although coronary artery bypass grafting (CABG) is still conventionally regarded as the standard of care for patients with significant ULMCA disease eligible for surgery,… View more

Vascular Disease and Surgery

Prevention & Chronic Conditions
Gerhard Hindricks
Research Area(s) / Expertise:

Atrial Arrhythmias

Electrophysiology & Arrhythmia

Pacing, Defibrillators & Cardiac Resynchronisation Therapy

Catheter Ablation of Cardiac Arrhythmias

 Job title: Medical Director
Gerhard Hindricks is a professor of cardiology at the Charite University Hospital, Berlin, Germany. He heads one of the largest electrophysiology departments in Europe, providing services for up to 5,000 patients and performing almost 2,500 interventions for arrhythmias each year. Prof Hindricks is editor-in-chief of EUROPACE magazine, and is past president of the European Heart Rhythm… View more
Martin Lowe
Dr Martin Lowe is a Consultant Cardiologist and Electrophysiologist, specialising in the treatment of arrhythmias in children with catheter ablation and pacemaker / defibrillator implantation.​ His research interests include ablation strategies in those with arrhythmias accompanying cardiomyopathy or congenital heart disease, risk stratification in patients and families predisposed to sudden… View more